Short course of systemic corticosteroids in sinonasal polyposis: A double-blind, randomized, placebo-controlled trial with evaluation of outcome measures

Hissaria, Pravin; Smith, William B.; Wormald, Peter John; Taylor, James; Vadas, MA; Gillis, David; Kette, Frank

doi:10.1016/j.jaci.2006.03.012

Cited by 199 publications

(72 citation statements)

References 20 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…12 It has been shown that patients with NP have lower scores in SF-36 than patients with coronary artery disease, asthma, and chronic obstructive pulmonary disease. 30,31 Hissaria et al 32 published the only study focusing specifically on NP using a modified RSOM-31 questionnaire. At baseline, they found average scores of 2.2 and 1.87 in patients to be treated with placebo and with corticosteroids, respectively.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Aeroallergen Sensitization Influences Quality of Life and Comorbidities in Patients with Nasal Polyposis

Dávila

Rondón

Navarro

et al. 2012

Am J Rhinol�Allergy

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…These results are lower than those found in our study, in which patients had an RSOM-31 average score of 3.53. However, such differences could be caused by the fact that Hissaria et al 32 used a modified questionnaire that only included severity scores. Unfortunately, the authors did not report any other RSOM-31 evaluations at baseline.…”

Section: Discussionmentioning

confidence: 99%

Aeroallergen Sensitization Influences Quality of Life and Comorbidities in Patients with Nasal Polyposis

Dávila

Rondón

Navarro

et al. 2012

Am J Rhinol�Allergy

View full text Add to dashboard Cite

show abstract

“…Hissaria et al 1024 randomized 41 subjects to receive 50 mg of prednisolone or placebo daily for 14 days. At the completion of treatment, both groups showed significant improvement in symptoms based on the physician interview and the RSOM scores, with the corticosteroid group demonstrating a significant improvement over the placebo group in each of these categories.…”

Section: Viiie3 Crswnp Management: Oral Corticosteroidsmentioning

confidence: 99%

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

Orlandi

Kingdom

Hwang

et al. 2016

Int Forum Allergy Rhinol

554

888

View full text Add to dashboard Cite

Background:The body of knowledge regarding rhinosinusitis (RS) continues to expand, with rapid growth in number of publications, yet substantial variability in the quality of those presentations. In an effort to both consolidate and critically appraise this information, rhinologic experts from around the world have produced the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR:RS). Methods:Evidence-based reviews with recommendations (EBRRs) were developed for scores of topics, using previously reported methodology. Where existing evidence was insufficient for an EBRR, an evidence-based review (EBR) was produced. The sections were then synthesized and the entire manuscript was then reviewed by all authors for consensus. Results:The resulting ICAR:RS document addresses multiple topics in RS, including acute RS (ARS), chronic RS (CRS) with and without nasal polyps (CRSwNP and CRSsNP), recurrent acute RS (RARS), acute exacerbation of CRS (AE-CRS), and pediatric RS. Conclusion:As a critical review of the RS literature, ICAR:RS provides a thorough review of pathophysiology and evidence-based recommendations for medical and surgical treatment. It also demonstrates the significant gaps in our understanding of the pathophysiology and optimal management of RS. Too o en the foundation upon which these recommendations are based is comprised of lowerlevel evidence. It is our hope that this summary of the evidence in RS will point out where additional research efforts may be directed. C 2016 ARS-AAOA, LLC. Key Words:rhinosinusitis; chronic rhinosinusitis; acute rhinosinusitis; recurrent acute rhinosinusitis; evidence-based medicine; systematic review; endoscopic sinus surgery List of Abbreviations Used

show abstract

“…It has been reported that in patients with AERD, the most common side effects of systemic corticosteroids include obesity, osteoporosis, arterial hypertension, and adrenal suppression. 5,40 Although i.v. corticosteroids are not a first line of treatment, AERD patients do receive steroids via this route.…”

Section: Corticosteroidsmentioning

confidence: 99%